Total Payments
$113,699
2024 Payments
$1,460
Companies
36
Transactions
380
Medicare Patients
10,168
Medicare Billing
$1.1M
Payment Breakdown by Category
Other$80,060 (70.4%)
Consulting$17,784 (15.6%)
Food & Beverage$11,139 (9.8%)
Travel$4,539 (4.0%)
Education$177.33 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $80,060 | 45 | 70.4% |
| Consulting Fee | $17,784 | 8 | 15.6% |
| Food and Beverage | $11,139 | 290 | 9.8% |
| Travel and Lodging | $4,539 | 30 | 4.0% |
| Education | $177.33 | 7 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $33,465 | 52 | $0 (2024) |
| GlaxoSmithKline, LLC. | $28,893 | 51 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $19,770 | 40 | $0 (2018) |
| Mylan Specialty L.P. | $10,772 | 33 | $0 (2024) |
| GENZYME CORPORATION | $6,284 | 30 | $0 (2024) |
| Insmed, Inc. | $5,133 | 31 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $4,954 | 18 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,616 | 34 | $0 (2024) |
| Genentech USA, Inc. | $489.47 | 9 | $0 (2019) |
| Circassia Pharmaceuticals Inc | $282.88 | 6 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,460 | 50 | AstraZeneca Pharmaceuticals LP ($264.81) |
| 2023 | $25,025 | 58 | GlaxoSmithKline, LLC. ($22,633) |
| 2022 | $5,582 | 45 | Insmed, Inc. ($4,583) |
| 2021 | $1,165 | 34 | Mylan Specialty L.P. ($292.71) |
| 2020 | $10,834 | 36 | GlaxoSmithKline, LLC. ($5,626) |
| 2019 | $16,593 | 48 | Mylan Specialty L.P. ($5,763) |
| 2018 | $19,703 | 39 | Boehringer Ingelheim Pharmaceuticals, Inc. ($15,187) |
| 2017 | $33,337 | 70 | Boehringer Ingelheim Pharmaceuticals, Inc. ($16,857) |
All Payment Transactions
380 individual payment records from CMS Open Payments — Page 1 of 16
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/05/2024 | ViiV Healthcare Company | RUKOBIA (Drug) | Food and Beverage | In-kind items and services | $14.79 | General |
| Category: HIV | ||||||
| 11/07/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $20.12 | General |
| Category: Respiratory | ||||||
| 11/06/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $13.77 | General |
| Category: Respiratory | ||||||
| 10/23/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $31.19 | General |
| Category: RESPIRATORY | ||||||
| 10/17/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $35.61 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/16/2024 | United Therapeutics Corporation | TYVASO (Drug) | Food and Beverage | In-kind items and services | $28.87 | General |
| Category: Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lung Disease | ||||||
| 10/16/2024 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $18.09 | General |
| Category: Pulmonology | ||||||
| 10/14/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $12.44 | General |
| Category: Respiratory | ||||||
| 10/10/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $20.69 | General |
| Category: Inflammation | ||||||
| 09/27/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $11.31 | General |
| Category: Immunology | ||||||
| 09/24/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $24.89 | General |
| Category: RESPIRATORY | ||||||
| 09/19/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $26.39 | General |
| Category: Cardiology | ||||||
| 09/18/2024 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: Pulmonology | ||||||
| 09/13/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $2.79 | General |
| Category: RESPIRATORY | ||||||
| 09/04/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $20.02 | General |
| Category: Respiratory | ||||||
| 08/27/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $19.54 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 08/21/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $56.25 | General |
| Category: Respiratory | ||||||
| 08/08/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $22.40 | General |
| Category: RESPIRATORY | ||||||
| 08/07/2024 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $17.08 | General |
| Category: Pulmonology | ||||||
| 08/06/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $16.76 | General |
| Category: Respiratory | ||||||
| 07/25/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $27.92 | General |
| Category: Cardiology | ||||||
| 07/24/2024 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $7.36 | General |
| Category: HFCWO | ||||||
| 07/11/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $24.44 | General |
| Category: RESPIRATORY | ||||||
| 07/10/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $10.54 | General |
| Category: Respiratory | ||||||
| 06/25/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $69.77 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 2,474 | 4,047 | $531,410 | $279,750 |
| 2022 | 18 | 2,711 | 4,417 | $552,887 | $279,921 |
| 2021 | 20 | 2,552 | 4,350 | $517,236 | $273,273 |
| 2020 | 21 | 2,431 | 3,870 | $502,894 | $252,518 |
Total Patients
10,168
Total Services
16,684
Medicare Billing
$1.1M
Procedure Codes
80
All Medicare Procedures & Services
80 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 700 | 1,407 | $211,050 | $133,445 | 63.2% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 166 | 375 | $67,500 | $34,463 | 51.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 151 | 268 | $34,840 | $16,372 | 47.0% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 46 | 345 | $31,050 | $15,907 | 51.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 119 | 119 | $35,700 | $14,443 | 40.5% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 510 | 680 | $40,800 | $13,423 | 32.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 72 | 95 | $19,000 | $12,800 | 67.4% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 108 | 114 | $22,800 | $11,448 | 50.2% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 45 | 45 | $13,500 | $6,028 | 44.7% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 106 | 114 | $9,120 | $4,901 | 53.7% |
| 94726 | Test to determine lung volumes using sensors | Office | 2023 | 106 | 114 | $9,120 | $4,702 | 51.6% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 114 | 126 | $12,348 | $3,676 | 29.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 21 | 21 | $7,350 | $3,421 | 46.5% |
| 31624 | Irrigation and suction of lung airways to obtain cells using an endoscope | Facility | 2023 | 21 | 21 | $10,500 | $1,940 | 18.5% |
| 94618 | Test for exercise-induced lung stress | Office | 2023 | 45 | 47 | $2,820 | $1,195 | 42.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 12 | 13 | $2,250 | $912.39 | 40.6% |
| 99406 | Smoking and tobacco use intensive counseling, 4-10 minutes | Office | 2023 | 26 | 29 | $522.00 | $414.70 | 79.4% |
| 85018 | Blood count, hemoglobin | Office | 2023 | 106 | 114 | $1,140 | $262.16 | 23.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 691 | 1,387 | $208,050 | $128,675 | 61.8% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 155 | 386 | $69,480 | $30,736 | 44.2% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 79 | 471 | $42,390 | $22,820 | 53.8% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2022 | 578 | 776 | $46,560 | $15,233 | 32.7% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 135 | 259 | $33,670 | $14,326 | 42.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 114 | 114 | $34,200 | $13,810 | 40.4% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 89 | 90 | $18,000 | $9,443 | 52.5% |
About Dr. Lorie Loreman, DO
Dr. Lorie Loreman, DO is a Critical Care Medicine healthcare provider based in Florence, South Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/09/2006. The National Provider Identifier (NPI) number assigned to this provider is 1285612291.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Lorie Loreman, DO has received a total of $113,699 in payments from pharmaceutical and medical device companies, with $1,460 received in 2024. These payments were reported across 380 transactions from 36 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($80,060).
As a Medicare-enrolled provider, Loreman has provided services to 10,168 Medicare beneficiaries, totaling 16,684 services with total Medicare billing of $1.1M. Data is available for 4 years (2020–2023), covering 80 distinct procedure/service records.
Ad
Practice Information
- Specialty Critical Care Medicine
- Other Specialties Pulmonary Disease
- Location Florence, SC
- Active Since 01/09/2006
- Last Updated 12/20/2024
- Taxonomy Code 207RC0200X
- Entity Type Individual
- NPI Number 1285612291
Products in Payments
- UTIBRON (Drug) $19,186
- Yupelri (Drug) $10,388
- DUPIXENT (Biological) $7,026
- STIOLTO RESPIMAT (Drug) $5,045
- Arikayce (Drug) $5,029
- DUPIXENT (Drug) $4,096
- LONHALA MAGNAIR (Drug) $570.00
- SPIRIVA (Drug) $494.06
- TRELEGY ELLIPTA (Drug) $486.01
- BREZTRI (Drug) $442.98
- YUPELRI (Drug) $372.48
- NUCALA (Biological) $351.19
- Xolair (Biological) $263.38
- AIRSUPRA (Drug) $257.27
- TYVASO (Drug) $239.40
- Prolastin-C Liquid (Biological) $222.44
- Inspire Upper Airway Stimulation System (Device) $214.02
- SYMBICORT (Drug) $193.55
- FLOWTRIEVER CATHETER, S (Device) $193.45
- OFEV (Drug) $163.79
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Critical Care Medicine Doctors in Florence
Irfan Budhani, Md, MD
Critical Care Medicine — Payments: $15,963
Critical Care Medicine $15,963
Dr. Oluseun Medeyinlo, M.d, M.D
Critical Care Medicine — Payments: $7,051
Critical Care Medicine $7,051
Mohamad Zein, Md, MD
Critical Care Medicine — Payments: $4,542
Critical Care Medicine $4,542
Dr. Latonya Brown, M.d, M.D
Critical Care Medicine — Payments: $3,975
Critical Care Medicine $3,975
Patricia Miles, M.d, M.D
Critical Care Medicine — Payments: $763.32
Critical Care Medicine $763.32
Brissa Westbrook, Np, NP
Critical Care Medicine — Payments: $621.93
Critical Care Medicine $621.93